Drug recalls

FDA drug recalls this week

FDA has posted no drug recalls yet the week of October 19, 2026.

License. openFDA publishes this file under CC0 1.0.

The last 3 recalls

None posted October 19 to 25, 2026 yet. FDA usually posts its Enforcement Report on Wednesday. Here are the last 3 recalls, the newest posted October 14, 2026.

Class II · Posted October 14, 2026 · Started September 11, 2026 · Ongoing

glycerin, hypromellose, polyethylene glycol 400; glycerin; +1 more

Product
Sterile Lubricant Dry Eye Relief Eye Drops, 0.5 FL OZ (15 mL); a) LEADER, DISTRIBUTED BY CARDINAL HEALTH, DUBLIN, OHIO 43017, www.myleader.com, NDC 70000-0502-1; b) Crocodile Tears, Distributed by: Crocodile Tears, Palm Beach Gardens, FL 33410, UPC: 8 67166 00000 4; c) Discount drug mart, Discount Drug Mart Food Fair, Medina, OH 44256, UPC: 0 93351 01156 6; d) exchange select, Manufactured for your Military Exchange By: K.C Pharmaceuticals, Inc., Pomona, CA 9176, UPC: 6 14299 05620 6; e) GERI CARE, Distributed by: Gericare Pharmaceuticals Corp., 1295 Towbin Ave., Lakewood, NJ 08701, NDC 57896-181-05; f) H.E.B Dry Eye, Eye Drops, MADE WITH PRIDE & CARE FOR H-E-B, SAN ANTONIO, TX 78204, UPC 0 41220 43741 2; g) Harris Teeter, PROUDLY DISTRIBUTED BY: HARRIS TEETER, LLC, MATTHEWS, NC 28105, UPC: 0 72036 71303 2; h) Foster & Thrive, Distributed by: McKesson Corp. Via Strategic Sourcing Servies LLC., Memphis, TN 38141, NDC 70677-1157-1; I) TopCare health, DISTRIBUTED BY TOPCO ASSOCIATES LLC, ELKGROVE VILLAGE, IL 60007, UPC 0 36800 36100 3.
Firm
K.C. Pharmaceuticals, Inc., Pomona, CA
Reason
Lack of Assurance of Sterility
Lots
Lot: a) LT25B01, Exp.: 02/28/2027; b) LT25D02, Exp.: 04/30/2027; LT25K01, Exp.: 09/30/2027; c) LT25D02, Exp.: 04/30/2027; LT25K01, Exp.: 09/30/2027; d) LT25D02, Exp.: 04/30/2027; LT25M02, Exp.: 10/31/2027; e) LT25B01, Exp.: 02/28/2027; LT25D01, Exp.: 04/30/2027; LT25D02, Exp.: 04/30/2027; LT25K01, Exp.: 09/30/2027; LT25M01, Exp.: 10/31/2027; LT25M02, Exp.: 10/31/2027; LT25N01, Exp.: 11/30/2027; LT25N02, Exp.: 11/30/2027; f) LT25B01, Exp.: 02/28/2027; g) LT25M02, Exp.: 10/31/2027; h) LT25B01, Exp.: 02/28/2027; I) LT25B01, Exp.: 02/28/2027; LT25D02, Exp.: 04/30/2027; LT25M02, Exp.: 10/31/2027.
Quantity
1,327,248 cartons
Distribution
US Nationwide
RxNorm
glycerin, hypromellose, polyethylene glycol 400; glycerin; polyethylene glycol 400 (RxCUI 259581, 2360899)
Recall number
D-0006-2027

Class II · Posted October 14, 2026 · Started September 10, 2026 · Ongoing

TIRZEPATIDE/CYANOCOBALAMIN 26/2 MG/ML INJECTABLE

Product
TIRZEPATIDE/CYANOCOBALAMIN 26/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936
Firm
Carolina Infusion, LLC, Ridgeland, SC
Reason
Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
Lots
Lot:07212026@18, BUD: 9/4/2026; 07222026@14, BUD: 9/5/2026; 07292026@8, BUD: 9/12/2026; 08052026@14, BUD: 9/19/2026; 08142026@1, BUD: 9/28/2026; 08192026@10, BUD: 10/3/2026; 08242026@25, BUD: 10/8/2026; 08282026@2, BUD: 10/12/2026; 08292026@1, BUD:10/13/2026;
Quantity
297 mL - in patient specific syringe dose
Distribution
Nationwide within the U.S
RxNorm
Not matched to RxNorm in the FDA record
Recall number
D-0027-2027

Class II · Posted October 14, 2026 · Started September 10, 2026 · Ongoing

QUAD-MIX( PAPAV/PHENTO/ALPROS/TROP) INJECTABLE

Product
QUAD-MIX( PAPAV/PHENTO/ALPROS/TROP) INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936
Firm
Carolina Infusion, LLC, Ridgeland, SC
Reason
Lack of Assurance of Sterility: Related to processing equipment used in compounded product.
Lots
LOT: 08032026@24, BUD: 09/17/2026.
Quantity
5 mls in patient specific syringe doses
Distribution
Nationwide within the U.S
RxNorm
Not matched to RxNorm in the FDA record
Recall number
D-0021-2027

Source: openFDA drug enforcement reports, as of October 21, 2026. Publisher page

Recent weeks

FDA posted drug recalls in 49 weeks of the last 52; 3 weeks had none.

Source: openFDA drug enforcement reports, as of October 21, 2026. Publisher page

About this data

Each row is one FDA drug enforcement report: one product from one firm. A week here is Monday to Sunday, keyed on the date FDA listed the recall in its weekly Enforcement Report. The date the firm started the recall is shown on each row and is often weeks earlier.

Class I means use of the product could cause serious health problems or death. Class II means it could cause temporary or reversible health problems. Class III means it is unlikely to cause health problems. RxNorm names and RxCUIs come from openFDA's match of the product to its drug label. Compounded products often have no match.

This page lists public records. It is not medical advice. Check the FDA record before acting on a recall.

Source: openFDA drug enforcement reports, as of October 21, 2026. Publisher page

Run it in Rivvi

Get this every Monday

Rivvi pulls the FDA drug recalls posted in the last 7 days and sends you the list each Monday morning. Add the drugs you care about and it flags any that match.

Watch recalls in Rivvi

Free to start. Opens Rivvi, the AI workspace for healthcare teams, with the weekly watch turned on.

Try it on your own data today.

Free to start. Most teams are using it the same day.

Get started for freeSee pricing
FDA drug recalls this week, October 19 to 25, 2026: none posted yet · Rivvi